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Abstract: Chlorhexidine (CHX), one of the most effective drugs administered for periodontal 
treatment, presents collateral effects including toxicity when used for prolonged periods; 
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here, we have evaluated the bactericidal potency and the cytocompatibility of Juniperus 
excelsa M. Bieb essential oil (EO) in comparison with 0.05% CHX. The EO was extracted 
from berries by hydrodistillation and components identified by gas chromatography and 
mass spectrometry. Bacterial inhibition halo analysis, quantitative cell viability 2,3-bis(2-
methoxy-4-nitro-5-sulphophenyl)-5-[(phenyl amino) carbonyl]-2H-tetrazolium hydroxide 
assay (XTT), and colony forming unit (CFU) count were evaluated against the two biofilm 
formers Aggregatibacter actinomycetemcomitans and Streptococcus mutans. Finally, 
cytocompatibility was assessed with human primary gingival fibroblasts (HGF) and 
mucosal keratinocytes (HK). The resulting EO was mainly composed of monoterpene 
hydrocarbons and oxygenated monoterpenes. An inhibition halo test demonstrated that 
both bacteria were sensitive to the EO; XTT analysis and CFU counts confirmed that  
10-fold-diluted EO determined a statistically significant (p < 0.05) reduction in bacteria 
count and viability towards both biofilm and planktonic forms in a comparable manner to 
those obtained with CHX. Moreover, EO displayed higher cytocompatibility than CHX  
(p < 0.05). In conclusion, EO exhibited bactericidal activity similar to CHX, but a superior 
cytocompatibility, making it a promising antiseptic alternative to CHX. 
Keywords: oral health; dental caries; periodontitis; antibiotic resistance; α-pinene; 
Streptococcus mutans; Aggregatibacter actinomycetemcomitans 
 
1. Introduction 
A number of biological niches are integrated into the human body, each of which is colonized by 
commensal organisms that, numerically speaking, overwhelm the eukaryotic cells, and that protect the 
organism from infection by pathogenic species. Their complexity has been characterized using new 
tools in metagenomics, developed within the Microbiome Project [1]. 
The oral cavity is one of the most important biological niches, containing hundreds of different 
species of bacteria, viruses, protozoa, and mycetes; these can become pathogens in response to drastic 
changes in their microenvironment, which occur normally throughout human life, and are normal in 
microbial physiology [2]. 
Supragingival plaque is mainly composed of Gram-positive bacteria, comprising Streptococcus 
sanguinis, S. mutans, S. mitis, S. salivarius, and lactobacilli, whereas the subgingival plaque primarily 
includes Gram-negative anaerobic bacteria, such as Aggregatibacter actinomycetemcomitans, Tannerella 
forsythia, Campylobacter spp., Capnocytophaga spp., Eikenella corrodens, Fusobacterium nucleatum, 
Porphyromonas gingivalis, Prevotella intermedia, and oral spirochetes such as Treponema denticola. 
In both the supragingival and the subgingival areas, the microbial communities on teeth and gingival 
tissues can accumulate high concentrations of bacterial metabolites in their microenvironment (e.g., 
fatty acid end-products, ammonia, hydrogen peroxide, oxidants and carbon dioxide), further 
influencing the growth of other bacterial species. 
Dental caries is closely related to the presence on the tooth surface of the oral biofilm, i.e., dental 
plaque, containing, among others, bacteria such as S. mutans, able to adhere to the tooth, proliferate, 
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and produce lactic acid, which dissolves the mineralized components of dental enamel and dentine. In 
the presence of sugars, S. mutans overwhelms the non-acid producers Streptococcus spp., which 
compose the supragingival biofilm. 
Caries is a very widespread disease, particularly in groups and populations living in poor  
socio-economic conditions. It severely affects the patient’s quality of life, because of acute pain as well 
as the progressive loss of dental hard tissue, and compromises related functions (mastication and 
aesthetics) leading, in the most severe cases, to tooth extraction [3]. 
Another possible result of oral microflora imbalance is the oral-biofilm-related disease 
periodontitis, a chronic inflammatory disease of the periodontium, i.e., the apparatus supporting the 
tooth in the alveolus; this condition affects nearly 65 million adults in the United States [4]. It is 
associated with the overgrowth of several pathogens that thus dominate the other bacteria. These include 
the micro-aerophylic bacteria of the biofilm, particularly A. actinomycetemcomitans; this latter species 
is a member of the natural resident microflora related to highly aggressive periodontitis. As indicated 
by the World Health Organization, periodontitis is a global issue, since it may be associated to certain 
autoimmune disorders and systemic inflammatory processes, e.g., coronary heart disease, metabolic 
imbalance, and complications in pregnancy [5]. For these reasons, countless diagnostic and therapeutic 
attempts have been made targeting the condition, and new strategies or electrochemically induced 
anatase activity have been attempted to eradicate this poly-microbial disease [6,7]. 
Concerns over antibiotic resistance are increasingly pressing, and it is important to restore the 
natural local microflora balance [8]. These strategies, combined or otherwise with the use of 
antimicrobial agents, seek to reduce or eliminate the extensive inflammatory response, while 
promoting proper local immune responses, hopefully with little or no host toxicity. The most widely 
employed and effective antimicrobial agent, with almost 40 years of use in a number of clinical 
applications, mainly in dentistry but also in dermatology, urology, gynecology and the veterinary field, 
is the FDA (Food and Drug Administration)-approved chlorhexidine (CHX) [9]. This bis-biguanide 
base, with cationic structure at physiological pH, has demonstrated wide-spectrum antibacterial 
activity. In dentistry, it is the most frequently prescribed and effective compound for plaque control, as 
an adjunct to mechanical oral hygiene [10], and has acquired the role of “gold standard” oral antiseptic 
agent, mainly in mouthwash formulations. However, despite CHX’s well-known properties, 
undesirable side effects can occur [11] and this molecule has been reported to be cytotoxic [12]. In the 
case of CHX abuse, this can lead to ulcerative and desquamative oral lesions [9]. Interestingly, in the 
perspective of long-term clinical use, low concentrations of CHX (0.05%–0.06%) have been reported 
to retain adequate anti-plaque efficacy, while reducing adverse effects [13]. 
Scientific interest is now growing with regard to new active ingredients other than CHX able to 
control the proliferation of pathogens, but preserving those microorganisms beneficial for the 
microenvironment, in full respect of host tissue integrity [14]. Certain essential oils (EOs), in 
particularly those extracted from Lippia sidoides by hydrodistillation of fresh leaves, are successful 
alternative antiseptic agents for oral care [10,15]. A recent meta-analysis reported a reduction similar 
or even superior to that produced by CHX in both dental plaque and gingival inflammation indexes 
when EOs were used for six months [10]. Interestingly, commercially available EOs, although not 
entirely innocuous, show milder side effects than CHX [16]. 
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Based on these premises, research efforts are now focusing on isolating novel plant-derived EOs, 
able to provide antibacterial effects against oral pathogens without affecting the oral microenvironment, 
that possess high biocompatibility. 
Juniperus excelsa is a tree species belonging to the Cupressaceae family, which includes about  
70 species widespread in Lebanon; it is used in traditional herbal medicine for its antifungal, 
disinfectant, and insect-repellent properties. Recent studies have evidenced its antimicrobial activity 
against the Gram positive S. aureus and the dermatophyte Trichophyton rubrum [17,18]. The present 
study aimed to better define the antibacterial properties of the EO extracted from the berries of  
J. excelsa, comparing them to those of digluconate CHX, against the two oral pathogens S. mutans and 
against A. actinomycetemcomitans. Inhibition halo, cell viability and colony-forming unit count were 
evaluated. The cytocompatibility of the EO versus primary human gingival fibroblasts and epithelial 
keratinocytes was also verified, to confirm the compounds’ in vitro safety. 
2. Results and Discussion 
2.1. Essential Oil Characterization 
The yield of the EO extracted from the berries of J. excelsa was 1.17%. The chemical composition 
of the EO is detailed in Table 1. Twenty-seven constituents were detected, in variable amounts. The 
components identified and quantified accounted for 98.1% of the total EO, mainly composed of 
monoterpene hydrocarbons. In particular, α-pinene was the most abundant compound (86.8%), while 
myrcene were the second most abundant metabolite (3.2%). 
Table 1. Chemical composition (%) and yield of essential oil obtained by hydrodistillation 
from berries of Juniperus excelsa M. Bieb. 
Ri a Ri b 
Yield % (v/w) Identification c 1.17 Compound ID 
938 1076 α-Pinene Ri, MS d, CoGC e 86.8 f 
980 1118 β-Pinene Ri, MS, CoGC 2.5 
993 1174 Myrcene Ri, MS, CoGC 3.2 
1013 1159 δ-3-Carene Ri, MS 2.4 
1030 1203 Limonene Ri, MS, CoGC 2.2 
1057 1255 γ-Terpinene Ri, MS, CoGC 0.3 
1143 1532 Camphor Ri, MS, CoGC T 
1152 1683 trans-Verbenol Ri, MS T 
1165 1587 Pinocarvone Ri, MS T 
1182 1864 p-Cymen-8-ol Ri, MS T 
1189 1706 α-Terpineol Ri, MS 0.4 
1217 1725 Verbenone Ri, MS 0.1 
1284 1597 Bornyl acetate Ri, MS, CoGC T 
1477 1726 D-Germacrene Ri, MS T 
1515 1776 δ-Cadinene Ri, MS T 
1604 2160 Cedrol Ri, MS, CoGC T 
  Monoterpene hydrocarbons  97.3 
  Oxygenated monoterpenes  0.8 
a: Retention index determined on a HP-5MS column; b: retention index determined on an Innovax column;  
c: Ri retention index identical to reported value; d: MS: identification by comparison of mass spectra;  
e: Co-GC: retention time identical to that of authentic compounds; f: bold numbers indicate percentages above 
2%, showing major components; T = traces, less than 0.05%. 
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2.2. Antibacterial Activity 
Both bacterial strains were found to be sensitive to the tested EO from J. excelsa berries. In 
particular, pure EO produced larger inhibition halos than 0.05% CHX, both on S. mutans (Figure 1A) 
and on A. actimomycetemcomitans (Figure 2A), with a statistically-significant difference in 
comparison with controls (p < 0.05). Inhibition halo areas of 1/10 diluted EO were smaller than CHX, 
though still significant towards controls for both S. mutans (Figure 1B) and A. actimomycetemcomitans 
(Figure 2B). 
 
 
Figure 1. Antibacterial activity of J. excelsa EO against S. mutans. (A) Bacteria growth 
was inhibited by pure (0) or 1/10 diluted EO (10); inhibition was statistically significant in 
comparison with controls (cnt) (p < 0.05, indicated by the *); (B) higher EO dilutions  
(100 or 1000) were ineffective; (C) XTT assay revealed a similar activity between CHX 
and EO (10), statistically different from controls (* p < 0.05) for both biofilm (left) and 
planktonic (right) cells; (D) CFUs counts showed that CHX and EO (10) determined a 
similar significant reduction of about 1.5 logs in comparison with control (* p < 0.05) for 
both biofilm (left) or planktonic (right) cells. Data are expressed as mean ± standard deviation. 
Results from the metabolic bacterial assay (XTT) showed that EO significantly decreased the 
viability of S. mutans (Figure 1C) and A. actimomycetemcomitans (Figure 2C), both in their biofilm 
(left graphic) and planktonic (right graphic) forms, compared with untreated controls (p < 0.05), 
similarly to CHX. Lastly, CFU counts of S. mutans (Figure 1D) and A. actimomycetemcomitans 
(Figure 2D), both in their biofilm (left graphic) and planktonic forms (right graphic) confirmed the 
data obtained with the XTT test. 
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Figure 2. Antibacterial activity of J. excelsa EO against A. actinomycetemcomitans.  
(A) Bacteria growth was inhibited by pure (0) or 1/10 diluted EO (10); inhibition was 
statistically significant in comparison with controls (cnt) (p < 0.05, indicated by the *);  
(B) higher EO dilutions (100 or 1000) were ineffective; (C) XTT assay revealed a similar 
activity between CHX and EO (10), statistically different towards controls (* p < 0.05) for 
both biofilm (left) and planktonic (right) cells; (D) CFUs counts showed that CHX and EO 
(10) determined a similar significant reduction of about 1.5 logs in comparison with 
control (* p < 0.05) for both biofilm (left) or planktonic (right) cells. Data are expressed as 
mean ± standard deviation. 
2.3. Cytocompatibility 
The effective 1/10 EO dilution determined a toxicity towards human cells that was significant to 
both gingival fibroblasts (HGFs, Figure 3A) and mucosal keratinocytes (HKs, Figure 3B); similar 
results were obtained with CHX. However, when comparing the 1/10 diluted EO and CHX groups, a 
statistical differences was noticed for both cell types, revealing a higher toxicity for CHX in 
comparison with EO (p < 0.05). 
2.4. Discussion 
J. excelsa EOs are novel active ingredients now being investigated for their potential as antiseptic 
agents for biomedical applications. They have been recently assayed for antimicrobial activity against 
the Gram-positive S. aureus and the dermatophyte Trichophyton rubrum [17,18]. This study, for the 
first time, investigated the preclinical efficacy of these products in oral care. EO from J. excelsa berries 
was tested against two major oral pathogens, i.e., A. actinomycetemcomitans and S. mutans, and, of 
note, primary human cells were used as the most appropriate way to test cytocompatibility. 
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Figure 3. In vitro cytocompatibility assay. The MTT test revealed that EO (10) and 
chlorhexidine caused a significant reduction (p < 0.05, indicated by the *) of cell viability 
for both fibroblasts (HGFs, left) and keratinocytes (HKs, right) in comparison with 
untreated control cells. However, EO (10) resulted significantly less toxic than CHX for 
both cell types (p < 0.05, indicated by the §). Higher oil dilutions (100 and 1000) were not 
toxic in comparison with control. Data are expressed as means ± standard deviations. 
The composition of the Lebanese J. excelsa EO used in this study is comparable to that of EOs from 
different geographical origins, previously reported in the literature, the most abundant constituent 
being α-pinene [19,20], as expected for a gymnosperm. Conversely, EOs of J. excelsa trees, cultivated 
in the United States and containing β-pinene (16.4%), limonene (11.6%) and bornyl acetate (10.4%) as 
their main constituents [21], are very different from the Middle-Eastern EOs. Interestingly, it has been 
proposed that the structure of the different EO components is related to their activity versus bacteria 
and the host cell. For instance, the presence of phenolic compounds, in particular containing the 
hydroxyl group, and the presence of an ester group in the structure of bornyl acetate have been 
reported to greatly enhance EO activity against several microorganisms [22]. This suggests the 
importance of identifying specific components and moieties, as well as the relevance of testing each 
newly isolated EO for both antibacterial and cytotoxic effects. 
In this study, the antimicrobial activity and cytocompatibility of J. excelsa EO were compared to 
those of CHX, a FDA-approved chemical antiseptic agent well known for its wide spectrum of action. 
Due to its ability to lyse the bacterial cell wall, by altering the osmotic balance of the bacterial cell, 
CHX is currently in use for numerous clinical applications, ranging from hand antisepsis in surgery to 
daily oral care. In particular, it can be considered the gold standard for dental plaque control, due to its 
efficacy against oral pathogens [9]. 
The present results support the antibacterial efficacy of EOs against A. actinomycetemcomitans and 
S. mutans. The inhibition halo test demonstrated the ability of EO to reduce the growth of bacteria. 
However, this assay alone cannot provide precise information concerning the relative effectiveness of 
one drug compared to another, since the size of the inhibition halo on the agar depends on several other 
factors. The first is the molecular weight of the compound, which inversely correlates with the size of 
the halo; this is followed by the compound’s density, which is directly correlated to halo size; finally, 
the electric charge of the compound can also influence its binding to the SO42− group of the agar, and 
thus bacteria migration. For this reason, after having established the general sensitivity of the test 
strains to the EO, a XTT reduction test and a cell propagation assay were run. These methods have 
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been approved for use, but only the XTT reduction assay is widely used, since it can accurately and 
rapidly determine bacteria cell viability, by reducing the key interference factors. The cell propagation 
assay is known for its high sensitivity, but it is time-consuming and more sensitive to cell aggregation 
levels than is the XTT test. Since an inhibition halo test provides only a general information on the 
antibacterial efficacy of the compound, it needs to be confirmed by further and more accurate evidence, 
via XTT and cell propagation assays. The experiments reported here show that the 1/10 diluted  
J. excelsa EO possess antimicrobial action against both A. actinomycetemcomitans and S. mutans, and 
that it is comparable to that of CHX used at a concentration of 0.05%. These data are consistent  
with reported findings of equivalent, or higher, in vitro antibacterial activity for EOs compared to  
CHX [23–25]. Of note, J. excelsa EOs showed lower cytotoxicity against both HGFs and HKs than 
CHX treatment; this is consistent with a study on human periodontal ligament fibroblasts [26]. The 
present study focused on the cytocompatibility of EOs with HGFs and HKs; these cells represent the 
best in vitro cellular model, since they come from the same species and the same anatomical site where 
the compounds will be used in vivo (i.e., the oral cavity). Moreover, they do not show aneuploidies or 
alterations, which could confuse the interpretation of the cellular response and, in addition, since 
human primary cells were isolated from a pool of three donors, they represent the properties of an 
entire population. 
3. Experimental Section 
3.1. Essential Oils 
3.1.1. Plant Material 
In October 2011, specimens of berries were collected from a 100-year-old Juniperus excelsa M. 
Bieb. tree growing on a natural site on the southern slopes of Hsayya, Qartaba, Mount Lebanon 
(34°05′55.35′′N 35°50′27.77′′E), at an altitude of about 1400 m. The plant material was dried in the 
shade for four weeks. Voucher specimens were deposited with the Herbarium of Botany, Medicinal 
Plant and Weed Science, Faculty of Agricultural and Food Sciences of U.S.E.K., Lebanon (registry 
number MNI018a–n). 
3.1.2. Essentials Oil Extraction 
The EO was extracted from the berries of J. excelsa by hydrodistillation for 3 h, using a  
Clevenger-type apparatus as indicated in the European Pharmacopoeia [27]. 
3.1.3. Essential Oil Analysis 
Gas Chromatography (GC). The GC analysis was carried out with a Thermo Electron apparatus 
(Thermo Electron Corporation, Beverly, MA, USA) equipped with a flame ionization detector (FID), 
an apolar DB-5 MS capillary column (30 m × 0.25 mm i.d., film thickness 0.1 mm, Agilent 
Technologies, Santa Clara, CA, USA), and a polar fused-silica HP Innowax capillary column 
(polyethylene glycol, 50 m × 0.20 mm i.d., film thickness 0.20 mm, Agilent Technologies). The oven 
temperature was programmed to rise from 35 °C to 85 °C at 5 °C min−1, held isothermal at 85 °C for 
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20 min, then rising from 85 °C to 300 °C at 10 °C/min, and finally held isothermal at 300 °C for 5 min; 
injector temperature, 250 °C; detector temperature, 310 °C; carrier gas, He (0.7 mL min−1). Aliquots of 
1 mL of the diluted samples (1:100 v/v) were injected both manually and in splitless mode. 
Gas Chromatography coupled to Mass Spectrometry (GC-MS). The GC-MS analysis was run on an 
Agilent 6890 gas chromatograph (Agilent Technologie) coupled with an Agilent 5975 mass-selective 
detector and equipped with an Agilent 7683 B auto sampler (injection of 1 mL of oil for each sample). 
The capillary columns and the GC conditions were those described above; source temperature, 310 °C; 
transfer-line temperature, 320 °C; ionization voltage, 70 eV; mass range, 50–400 amu (full scan mode). 
Identification and quantification of EO components. Identification of the EO constituents was based 
on: (i) retention indices (RIs), determined relative to the tR of n-alkanes (C8–C24) on both capillary 
columns, and compared with those reported in the literature [28] or with those of authentic compounds 
obtained from the manufacturer (Sigma-Aldrich, Beirut, Lebanon); and (ii) mass spectra, compared 
with those listed in the commercial mass spectral libraries NIST, Wiley 275 and in a home-made 
library, or with those reported in the literature [28,29]. Standards of selected EOs of known 
composition (e.g., the essential oil of Rosmarinus officinalis L. from Phytosun Aroms, Plélo, France) 
were injected under similar conditions for the comparison of tR and mass spectra. The relative contents 
of the oil components were calculated based on the GC-FID peak areas without using correction factors. 
3.2. Antibacterial Activity of Essential Oils 
3.2.1. Bacterial Strains and Growth Conditions 
Two exponentially growing oral biofilm pathogen strains were used to evaluate the antibacterial 
activity of the EO: (i) Streptococcus mutans (DSMZ 20523, Leibniz Institute DSMZ-German 
Collection of Microorganisms and Cell Cultures, Braunschweig, Germany) and (ii) Aggregatibacter 
actinomycetemcomitans (DSMZ 11123). Bacteria were cultivated on blood-agar plates (Sintak S.r.l., 
Corsico, Milan, Italy) at 37 °C, under aerobic conditions, for 48 h until round single colonies were 
obtained. Plates were then stored at 4 °C until use. 
3.2.2. Biofilm and Planktonic Bacterial Cells 
Antibacterial activity of the EO was tested against biofilm and planktonic cells of both S. mutans 
and A. actinomycetemcomitans species. 500 mL of each fresh bacterial culture were prepared by 
inoculating about 4–5 single colonies of each strain into Luria Bertani broth (LB, Sigma-Aldrich, 
Milan, Italy). Cultures were incubated at 37 °C in a Gallenkamp orbital shaker incubator at 16 g for 16 h. 
Exponentially-growing bacterial suspensions were then diluted in fresh LB medium at a final 
concentration of 1 × 108 cells mL−1 according to the McFarland standard 1.0. One hundred µL  
(1 × 107 cells mL−1) of the diluted cultures were collected, spotted into 96-well plates (CellStar, PBI 
International, Milan, Italy) and incubated at 37 °C in rotation (6 g) for 90 min (adhesion phase). The 
supernatant containing planktonic cells was then removed from each well and transferred onto a new 
plate, while biofilm cells, attached to the bottom of the empty wells were rinsed with 100 µL of fresh 
LB medium (separation phase). 
Molecules 2015, 20 9353 
 
 
3.2.3. Essential Oil Treatment 
EO and CHX were diluted in 10% dimethyl sulphoxide (DMSO, Sigma-Aldrich) in 1x phosphate 
buffered saline (PBS, Sigma-Aldrich). Different dilutions of EO were added to each well containing 
planktonic or biofilm cells, as follows: 0 = pure essential oil; 10 = 1/10; 100 = 1/100; 1000 = 1/1000. 
Digluconate CHX at 0.05% was used as positive control, while LB medium alone plus 10% DMSO 
was used as untreated control. Experiments were performed in quadruplicate. 
3.2.4. Inhibition Halo 
In order to evaluate bacterial strain sensitivity towards the EO, 1 mL of a suspension of  
1 × 107 bacterial cells mL−1 was spotted and distributed uniformly over the surface of Petri dishes 
containing LB agar medium. Plates were air dried for 20 min in a laminar flow hood (Heraeus, 
Herasafe HS 15, Burladingen, Germany) and 0.5 cm diameter sterile paper disks, previously soaked 
with 20 µL of the pure/diluted EO or 0.05% CHX, were then placed over the plated surface. Plates 
were incubated for 24 h at 37 °C and, the following day, the inhibition halo was measured, i.e., the 
bacteria-free area around the treated paper disk. As untreated control, a disk soaked in LB medium 
alone plus 10% DMSO was placed in the centre of each plate. Experiments were performed in 
quadruplicate for each chemical and bacterial strain. 
3.2.5. Bacterial Cell Viability 
To assess the growth capacity of the bacterial strains after 24 h of direct essential oil contact 
compared to that of untreated controls, bacterial viability was evaluated by the validated quantitative 
colorimetric metabolic 2,3-bis (2-methoxy-4-nitro-5-sulphophenyl)-5-[(phenyl amino) carbonyl]-2H-
tetrazolium hydroxide assay (XTT, Sigma-Aldrich). Briefly, 20 µL of XTT solution (3 mg mL−1 in 
acetone containing 0.1M menadione) were added to each well and plates were incubated at 37 °C for  
5 h in the dark. 50 µL were then collected from each well and centrifuged for 2 min at 480 g to remove 
any debris, and the optical density was evaluated using a spectrophotometer (SpectraCount, IBM,  
New York, NY, USA) at 690 nm. 
3.2.6. Colonies Forming Units (CFU) Counts 
After 24 h of direct contact with the EO, a colony forming unit (CFU) count was conducted as 
described by Harrison et al. [30]. Briefly, 100 µL of supernatant were collected from each well and used 
to perform six serial ten-fold dilutions, mixing 20 µL of bacterial suspension with 180 µL of sterile 
saline (0.9% NaCl). Twenty µL were then collected from each dilution, spotted onto plates containing 
LB agar medium, and incubated for 24 h at 37 °C. Lastly, the CFU mL−1 were counted as follows: 
CFU = [(number of colonies x dilution factor)(serial dilution)]  
where: 
number of colonies = countable single round colonies; 
dilution factor = dilution made from the initial 1 mL suspension; 
serial dilution = 1–6 ten-fold dilution areas where colonies were counted. 
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3.3. Cytocompatibility Evaluation of Essential Oils 
3.3.1. Cells 
Cytotoxic activity of EO was evaluated on pooled primary human gingival fibroblasts (HGFs) and 
mucosal keratinocytes (HKs). HGFs were isolated from discarded normal human gingiva, surgically 
resected from healthy patients. All subjects gave informed consent to participate to the study, which 
was conducted according to the Declaration of Helsinki. Briefly, thin sheets of mucosa were removed 
using a dermatome, and the epithelial layer was enzymatically detached through simple digestion with 
0.5% dispase at 4 °C O/N. The dermal layer was then minced with surgical blades and digested for  
30 min at 37 °C with a collagenase/dispase/trypsin solution (1 mg mL−1 collagenase, 0.3 mg mL−1 
dispase, 0.25% trypsin in PBS, all from Sigma-Aldrich). Cells were then cultivated in α-MEM  
(Sigma-Aldrich) supplemented with 10% heat-inactivated fetal bovine serum FBS (Sigma-Aldrich) 
and 1% antibiotics-antimycotics (Anti-Anti, Sigma-Aldrich) at 37 °C in a humidified 10% CO2 
atmosphere. HK were obtained from Clonetics (Euroclone, Milan, Italy) and maintained in EpiLife® 
Medium (Invitrogen, Milan, Italy). Before confluence, both cell types were trypsinized, re-suspended, 
plated for the experiments, and used within fifteen population doublings. 
3.3.2. Cell Viability Determination 
Both HGFs and HKs (2 × 104 cells well−1) were seeded onto 96-well plates. Cells were allowed to 
adhere overnight, and then the EO was added to each well, at the same dilutions used for the 
antibacterial activity assay. After 24 h of direct contact with EOs, cell viability was determined using 
the colorimetric metabolic assay 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 
Sigma-Aldrich). Briefly, 20 µL of MTT solution (3 mg mL−1 in PBS) were spotted onto each well; 
plates were incubated for 4 h in the dark at 37 °C in an incubator. The medium was then removed, and 
the formazan crystals on the well bottom were dissolved in 100 µL DMSO. Lastly, 50 µL aliquots 
were collected from each well and the optical density measured with the spectrophotometer, at 570 nm. 
Cells cultivated with medium alone plus 10% DMSO were considered untreated controls; data were 
expressed as % viability related to 100% of controls. The viability of cells treated with EOs was also 
compared to that measured in the presence of 0.05% CHX. Experiments were carried out in quadruplicate. 
3.4. Statistical Analysis of Data 
Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS v. 
20.0, IBM, Atlanta, GA, USA). Data were statistically compared by one-way ANOVA followed by 
Sheffe’s test for post-hoc analysis. The significance level was set at p < 0.05. 
4. Conclusions 
Our results support in vitro evidence of cytocompatibility and antibacterial activity of novel EO 
extracted from Lebanese Juniperus excelsa M. Bieb. The EO does not affect cell survival of primary 
HGFs and HEKs, while retaining its antibacterial activity against two common oral pathogens,  
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A. actinomycetemcomitans and S. mutans. Conversely, the data confirm the harmful effects on cell 
viability of 0.05% CHX, whose antibacterial efficacy is comparable to that of the EOs. 
Within the limitations of this preclinical study, the results suggest that innovative formulations for 
oral health, based on J. excelsa EO, are promising candidates as safe and effective alternatives to the 
current gold standard antiseptic agent, i.e., CHX, which is not without cytotoxicity and adverse effects. 
Further investigations will be needed to confirm the clinical efficacy of these compounds, and to 
examine in greater depth the significance of the present findings. 
Acknowledgments 
We thank Frances Cooper for the English language revision. 
Fondi “Ricerca Locale 2010” and “Fondazione Cariplo 2013” supported this study (University of 
Piemonte Orientale). 
Author Contributions 
M.I., B.A., A.C. and E.M.V. conceived the idea and wrote the manuscript; M.E.B. provided the 
essential oils and carried out GC-MS analyses; F.U., R.S. and M.M.L. carried out the experiments; 
L.R. and M.I. evaluated the data. All authors contributed to the interpretation of the results and 
commented on the manuscript. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Ding, T.; Schloss, P.D. Dynamics and associations of microbial community types across the 
human body. Nature 2014, 509, 357–360. 
2. O’Malley, M.A. Everything is everywhere: But the environment selects: Ubiquitous distribution 
and ecological determinism in microbial biogeography. Stud. Hist. Philos. Biol. Biomed. Sci. 
2008, 39, 314–325. 
3. Schwendicke, F.; Dörfer, C.E.; Schlattmann, P.; Page, L.F.; Thomson, W.M.; Paris, S. Socioeconomic 
Inequality and Caries: A Systematic Review and Meta-Analysis. J. Dent. Res. 2015, 94, 10–18. 
4. Southerland, J.H.; Taylor, G.W.; Moss, K.; Beck, J.D.; Offenbacher, S. Commonality in chronic 
infammatory diseases: Periodontitis, diabetes and coronary artery disease. Periodontol. 2000 
2006, 40, 130–143. 
5. Ehrlich, G.D.; Hu, F.Z.; Sotereanos, N.; Sewicke, J.; Parvizi, J.; Nara, P.L.; Arciola, C.R. What 
role do periodontal pathogens play in osteoarthritis and periprosthetic joint infections of the knee?  
J. Appl. Biomater. Funct. Mater. 2014, 12, 13–20. 
6. Cochis, A.; Azzimonti, B.; Della Valle, C.; Chiesa, R.; Arciola, C.R.; Rimondini, L. Biofilm 
formation on titanium implants counteracted by grafting gallium and silver ions. J. Biomed. 
Mater. Res. A 2015, 103, 1176–1187. 
Molecules 2015, 20 9356 
 
 
7. Giordano, C.; Saino, E.; Rimondini, L.; Pedeferri, M.P.; Visai, L.; Cigada, A.; Chiesa, R. 
Electrochemically induced anatase inhibits bacterial colonization on Titanium Grade 2 and Ti6Al4V 
alloy for dental and orthopedic devices. Colloids Surf. B Biointerfaces 2011, 88, 648–655. 
8. Zaura, E.; Nicu, E.A.; Krom, B.P.; Keijser, B.J. Acquiring and maintaining a normal oral 
microbiome: Current perspective. Front. Cell Infect. Microbiol. 2014, 4, 85, 
doi:10.3389/fcimb.2014.00085. 
9. Varoni, E.; Tarce, M.; Lodi, G.; Carrassi, A. Chlorhexidine (CHX) in dentistry: State of the art. 
Minerva Stomatol. 2012, 61, 399–419. 
10. Brambilla, E.; Ionescu, A.; Gagliani, M.; Cochis, A.; Arciola, C.R.; Rimondini, L. Biofilm 
formation on composite resins for dental restorations: An in situ study on the effect of 
chlorhexidine mouthrinses. Int. J. Artif. Organs 2012, 35, 792–799. 
11. Eick, S.; Goltz, S.; Nietzsche, S.; Jentsch, H.; Pfister, W. Efficacy of chlorhexidine  
digluconate-containing formulations and other mouthrinses against periodontopathogenic 
microorganisms. Quintessence Int. 2011, 42, 687–700. 
12. Hidalgo, E.; Dominguez, C. Mechanisms underlying chlorhexidine-induced cytotoxicity.  
Toxicol. In Vitro 2001, 15, 271–276. 
13. Hoffmann, T.; Bruhn, G.; Richter, S.; Netuschil, L.; Brecx, M. Clinical controlled study on plaque 
and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population 
exhibiting good oral hygiene. Clin. Oral Investig. 2001, 5, 89–95. 
14. Cochis, A.; Fracchia, L.; Martinotti, M.G.; Rimondini, L. Biosurfactants prevent in vitro Candida 
albicans biofilm formation on resins and silicon materials for prosthetic devices. Oral Surg. Oral 
Med. Oral Pathol. Oral Radiol. 2012, 113, 755–761. 
15. Van Staden, A.D.; Dicks, L.M. Calcium orthophosphate-based bone cements (CPCs): 
Applications, antibiotic release and alternatives to antibiotics. J. Appl. Biomater. Funct. Mater. 
2012, 10, 2–11. 
16. Hammer, K.A.; Heel, K.A. Use of multiparameter flow cytometry to determine the effects of 
monoterpenoids and phenylpropanoids on membrane polarity and permeability in staphylococci 
and enterococci. Int. J. Antimicrob. Agents 2012, 40, 239–245. 
17. Khoury, M.; El Beyrouthy, M.; Ouaini, N.; Iriti, M.; Eparvier, V.; Stien, D. Chemical composition 
and antimicrobial activity of the essential oil of Juniperus excelsa M. Bieb. growing wild in 
Lebanon. Chem. Biodivers. 2014, 11, 825–830. 
18. Fadli, M.; Chevalier, J.; Saad, A.; Mezrioui, N.E.; Hassani, L.; Pages, J.M. Essential oils from 
Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative 
bacteria. Int. J. Antimicrob. Agents 2011, 38, 325–330. 
19. Ünlü, M.; Vardar-Unlü, G.; Vural, N.; Donmez, E.; Ozbas, Z.Y. Chemical composition, 
antibacterial and antifungal activity of the essential oil of Thymbra spicata L. from Turkey.  
Chem. Nat. Compd. 2009, 23, 572–579. 
20. Weli, A.M.; Al-Hinai, S.R.K.; Hossain, M.M.; Al-Sabahi, J.N. Composition of essential oil of 
Omani Juniperus excelsa fruit and antimicrobial activity against foodborne pathogenic bacteria.  
J. Taibah Univ. Sci. 2014, 8, 225–230. 
Molecules 2015, 20 9357 
 
 
21. Cantrell, C.L.; Zheljazkov, V.D.; Carvalho, C.R.; Astatkie, T.; Jeliazkova, E.A.; Rosa, L.H. Dual 
Extraction of Essential Oil and Podophyllotoxin from Creeping Juniper (Juniperus horizontalis). 
PLoS ONE 2014, 9, e106057. 
22. Nizar, Y.S.; Muller, C.D.; Lobstein, A. Major bioactivities and mechanism of action of essential 
oils and their components. Flavour Fragr. J. 2013, 28, 269–279. 
23. Takarada, K.; Kimizuka, R.; Takahashi, N.; Honma, K.; Okuda, K.; Kato, T. A comparison of the 
antibacterial efficacies of essential oils against oral pathogens. Oral Microbiol. Immunol. 2004, 
19, 61–64. 
24. Pan, P.C.; Harper, S.; Ricci-Nittel, D.; Lux, R.; Shi, W. In-vitro evidence for efficacy of 
antimicrobial mouthrinses. J. Dent. 2010, 38, 16–20. 
25. Quintas, V.; Prada-López, I.; Prados-Frutos, J.C.; Tomás, I. In situ antimicrobial activity on oral 
biofilm: Essential oils vs. 0.2% chlorhexidine. Clin. Oral Investig. 2015, 19, 97–91. 
26. Tsourounakis, I.; Palaiologou-Gallis, A.A.; Stoute, D.; Maney, P.; Lallier, T.E. Effect of essential 
oil and chlorhexidine mouthwashes on gingival fibroblast survival and migration. J. Periodontol. 
2013, 84, 1211–1220. 
27. Zhu, J.; Lower-Nedza, A.D.; Hong, M.; Jie, S.; Wang, Z.; Yingmao, D.; Tschiggerl, C.;  
Bucar, F.; Brantner, A.H. Chemical composition and antimicrobial activity of three essential oils 
from Curcuma wenyujin. Nat. Prod. Commun. 2013, 8, 523–526. 
28. Helmi, Z.; Al Azzam, K.M.; Tsymbalista, Y.; Ghazleh, R.A.; Shaibah, H.; Aboul-Enein, H. 
Analysis of Essential Oil in Jerusalem Artichoke (Helianthus tuberosus L.) Leaves and Tubers by 
Gas Chromatography-Mass Spectrometry. Adv. Pharm. Bull. 2014, 4, 521–526. 
29. Adams, R.P. Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy. 
J. Am. Soc. Mass Spectrom. 2005, 16, 1902–1903. 
30. Harrison, J.J.; Stremick, C.A.; Turner, R.J.; Allan, N.D.; Olson, M.E.; Ceri, H. Microtiter 
susceptibility testing of microbes growing on peg lids: A miniaturized biofilm model for  
high-throughput screening. Nat. Protoc. 2010, 5, 1236–1254. 
Sample Availability: Sample of the essential oil is available from the authors. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
